EviCore by Evernorth: Company Profile

Background

EviCore by Evernorth is a leading medical benefits management company headquartered in Bluffton, South Carolina. Established in 2014 through the merger of MedSolutions, Inc., and CareCore National, EviCore specializes in managing prior authorizations for specialized medical procedures on behalf of insurers. The company's mission is to ensure that patients receive safe, effective, and evidence-based care while optimizing healthcare costs. EviCore operates as a subsidiary of Evernorth, the health services division of Cigna, and is recognized as the largest prior authorization company in the United States, serving over 100 million individuals nationwide.

Key Strategic Focus

EviCore's strategic focus centers on delivering integrated medical benefits management solutions that enhance care quality and reduce unnecessary expenditures. The company offers a comprehensive suite of services, including utilization management, decision support, case management, member engagement, network management, and payment integrity. EviCore's core objectives include:

Evidence-Based Care: Utilizing guidelines developed with input from medical specialty societies, peer-reviewed literature, academic institutions, and community physicians to promote appropriate care.

Technological Integration: Implementing advanced technologies such as the IntelliPath® platform to streamline prior authorization processes and reduce administrative burdens for providers.

Market Expansion: Partnering with over 100 insurance companies, including major players like Aetna, Blue Cross Blue Shield, and UnitedHealthcare, as well as Medicaid programs, to extend its reach and impact.

Financials and Funding

EviCore was acquired by Express Scripts in December 2017 for $3.6 billion, marking a significant expansion into medical benefits management. Following Cigna's acquisition of Express Scripts in December 2018, EviCore became part of Evernorth, Cigna's health services division. As of January 2025, EviCore's annual revenue reached approximately $5 billion.

Technological Platform and Innovation

EviCore distinguishes itself through its proprietary technological platforms and innovative methodologies:

IntelliPath® Platform: Launched in 2020, IntelliPath® is an advanced prior authorization platform embedded within electronic health records. It automates approvals for requests meeting clinical guidelines and provides real-time feedback to providers, thereby reducing administrative burdens and expediting care delivery.

Artificial Intelligence Algorithms: EviCore employs AI-driven algorithms to assess the likelihood of claim approvals, optimizing the prior authorization process and enhancing decision-making efficiency.

Leadership Team

EviCore's leadership team comprises experienced professionals dedicated to advancing the company's mission. Key executives include:

John Arlotta: Chairman and CEO, instrumental in guiding EviCore's strategic direction and growth initiatives.

Eric Gratias, M.D.: Chief Medical Officer, overseeing clinical strategies and ensuring the implementation of evidence-based care practices.

Competitor Profile

Market Insights and Dynamics

The medical benefits management industry is a critical component of the healthcare system, focusing on optimizing care delivery and controlling costs. The market is characterized by the increasing complexity of medical procedures and the need for efficient utilization management solutions.

Competitor Analysis

EviCore operates in a competitive landscape with several key players:

AIM Specialty Health: Founded in 1989 and headquartered in Chicago, Illinois, AIM Specialty Health offers similar services in the health care services industry.

HealthHelp: Established in 1999 in Houston, Texas, HealthHelp provides medical benefits management solutions, operating in the same field as EviCore.

Carelon Medical Benefits Management: A subsidiary of Elevance Health (formerly Anthem), Carelon offers medical benefits management services and has been involved in legal challenges regarding coverage denials.

Strategic Collaborations and Partnerships

EviCore has established strategic partnerships with major industry players, including Aetna, Express Scripts, and Concert Genetics. These collaborations enhance EviCore's service offerings and expand its client base.

Operational Insights

EviCore's operational strategy focuses on leveraging advanced technologies and evidence-based guidelines to deliver efficient and effective medical benefits management. The company's integration of AI algorithms and platforms like IntelliPath® positions it as a leader in streamlining prior authorization processes and reducing administrative burdens for providers.

Strategic Opportunities and Future Directions

Looking ahead, EviCore aims to:

Expand Technological Capabilities: Continue enhancing its AI-driven platforms to improve decision-making processes and operational efficiency.

Broaden Market Reach: Strengthen partnerships with additional insurers and healthcare providers to extend its services to a larger patient population.

Enhance Evidence-Based Practices: Regularly update clinical guidelines in collaboration with medical societies to ensure the delivery of appropriate and effective care.